Play Video This will play a video - Understand the prevalence of OAB in senior living facilities, learn how PTNM can help, and hear from patients who have benefitted from treatment.

PERCUTANEOUS TIBIAL NEUROMODULATION PTNM FOR SENIOR LIVING FACILITIES

Actively treating urinary incontinence in your facility can help you meet important objectives.
CONTROL THE COSTS AND RISKS

RESTORE DIGNITY AND QUALITY OF LIFE<sup>1</div>

PTNM is a minimally invasive therapy option that puts you — and your residents — in control.

GET AN OVERVIEW OF PTNM
Play Video This will play a video - Animation showing the percutaneous tibial neuromodulation procedure delivered with the Medtronic NURO system

NURO PTNM Procedure Animation

High Stakes

FOR SENIORS

Bladder control issues affect nearly 3 out of 4 long-term care residents2 — with serious risks.

DISCOVER THE IMPACT OF OAB

CANDIDATES FOR PTNM

Expand options for residents who have overactive bladder (OAB).

VIEW GUIDELINES

HOW TO ORDER

Find instructions for ordering the NURO™ system.

ORDER NURO

$5.3 BILLION

Annual Cost of Managing

Incontinence<sup>3,4</sup>

STOP MANAGING INCONTINENCE, START TREATING IT

PTNM delivered by the NURO™ system is clinically proven to restore* bladder function — not just manage urinary incontinence symptoms.

VIEW CLINICAL DATA

Most common side effects are temporary and include mild pain or skin inflammation at or near the stimulation site.

*

Restored bladder function is defined as a measurable reduction in urinary frequency and/or urinary incontinence episodes following treatment.

1

Gorina Y, Schappert S, Bercovitz A, et al. Prevalence of incontinence among older Americans. Vital Health Stat 3. 2014;(36):1-33

2

Urinary Incontinence in the  Long-Term Care Setting. Clinical Practice Guideline. AMDA. 2012. Pgs1-48

3

Hu TW, Wagner TH, Bentkover JD, et al. Costs of urinary incontinence  and overactive bladder in the  United States: a comparative study.  Urology.  2004 Mar;63(3):461-5.

4

Kobashi K, Margolis E, Sand P, et al. Prospective Study to Evaluate Quality of Life with Percutaneous Tibial Neuromodulation in Drug- Naïve Patients with Overactive Bladder Syndrome. Presented at the 2018 Annual Meeting of the International Continence Society.